Key result
NT-proBNP serves as a useful biomarker for diagnosing and monitoring preeclampsia, peripartum cardiomyopathy, and impending heart failure in pregnant women.
Why the study?
Does NT-proBNP measurement improve diagnosis and risk stratification for heart failure in pregnant women?
Does NT-proBNP measurement improve diagnosis and risk stratification for heart failure in pregnant women?
NT-proBNP measurement is a useful tool for diagnosing and monitoring heart failure risk in pregnant women with cardiac conditions, highlighting the need for further research in this population.
No takes yet. Share an insight, caveat, or question.
May inform HF risk stratification in pregnancy; leaves open prospective validation before clinical adoption.
Ker et al. (2017) conducted a review in Pregnancy with cardiac conditions. NT-proBNP was evaluated. NT-proBNP serves as a useful biomarker for diagnosing and monitoring preeclampsia, peripartum cardiomyopathy, and impending heart failure in pregnant women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: